Mario P. Bonomini

Chieti, 66100, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 108 publications

Autosomal Dominant Tubulointerstitial Kidney Disease-UMOD: Case Report and Disease Update.

Autosomal Dominant Tubulointerstitial Kidney Disease-UMOD: Case Report and Disease Update.

Journal: Diagnostics (Basel, Switzerland)

Published: April 01, 2026

Missing Opportunity for Nephroprotective Therapy in Patients With Non-Dialysis CKD Under Stable Nephrology Care.

Missing Opportunity for Nephroprotective Therapy in Patients With Non-Dialysis CKD Under Stable Nephrology Care.

Journal: Kidney international reports

Published: February 05, 2026

Dialysis Unit Differences in Post-Dialysis Fatigue Prevalence and Characteristics and Time to Recovery After Dialysis.

Dialysis Unit Differences in Post-Dialysis Fatigue Prevalence and Characteristics and Time to Recovery After Dialysis.

Journal: Hemodialysis international. International Symposium on Home Hemodialysis

Published: November 21, 2025

Hemodialysis Timing Influences Sleep Profile.

Hemodialysis Timing Influences Sleep Profile.

Journal: Kidney360

Published: May 29, 2025

Sweeteners: erythritol, xylitol and cardiovascular risk-friend or foe?

Sweeteners: erythritol, xylitol and cardiovascular risk-friend or foe?

Journal: Cardiovascular research

Published: December 06, 2024

Elevated serum xylitol levels and cardiovascular risk: an active component or an innocent bystander?

Elevated serum xylitol levels and cardiovascular risk: an active component or an innocent bystander?

Journal: European heart journal

Published: November 20, 2024

Survey and Intervention Tools for Burnout in Dialysis Healthcare Staff

Survey and Intervention Tools for Burnout in Dialysis Healthcare Staff

Journal: Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia

Published: November 07, 2024

Difelikefalin for CKD-aP: real world evidence of efficacy and safety in Italian patients.

Difelikefalin for CKD-aP: real world evidence of efficacy and safety in Italian patients.

Journal: Clinical kidney journal

Published: September 06, 2024

Rationale and design of ELIXIR, a randomized, controlled trial to evaluate efficacy and safety of XyloCore, a glucose-sparing solution for peritoneal dialysis.

Rationale and design of ELIXIR, a randomized, controlled trial to evaluate efficacy and safety of XyloCore, a glucose-sparing solution for peritoneal dialysis.

Journal: Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis

Published: August 29, 2024

Aldosterone Synthase Inhibitors for Cardiorenal Protection: Ready for Prime Time?

Aldosterone Synthase Inhibitors for Cardiorenal Protection: Ready for Prime Time?

Journal: Kidney & blood pressure research

Published: July 16, 2024

Hallmarks for Thrombotic and Hemorrhagic Risks in Chronic Kidney Disease Patients.

Hallmarks for Thrombotic and Hemorrhagic Risks in Chronic Kidney Disease Patients.

Journal: International journal of molecular sciences

Published: June 20, 2024

Clinical and Economic Impact of Early Diagnosis of Chronic Kidney Disease in General Practice: The Endorse Study.

Clinical and Economic Impact of Early Diagnosis of Chronic Kidney Disease in General Practice: The Endorse Study.

Journal: ClinicoEconomics and outcomes research : CEOR

Published: May 28, 2024

Showing 1-12 of 108

Last Updated: 09/26/2026